These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

793 related articles for article (PubMed ID: 21474174)

  • 21. 25 by 25: Achieving Global Reduction in Cardiovascular Mortality.
    Dugani S; Gaziano TA
    Curr Cardiol Rep; 2016 Jan; 18(1):10. PubMed ID: 26748650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-communicable diseases and health systems reform in low-and-middle-income countries.
    Robinson HM; Hort K
    Pac Health Dialog; 2012 Apr; 18(1):179-90. PubMed ID: 23240355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Health policy interventions: the pathway to public health].
    Andersen K; Gudnason V
    Laeknabladid; 2013 Mar; 99(3):129-34. PubMed ID: 23486685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baseline status of policy and legislation actions to address non communicable diseases crisis in the Pacific.
    Win Tin ST; Kubuabola I; Ravuvu A; Snowdon W; Durand AM; Vivili P; Passmore E
    BMC Public Health; 2020 May; 20(1):660. PubMed ID: 32398159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Raising the priority of chronic noncommunicable diseases in the Caribbean.
    Hospedales CJ; Samuels TA; Cummings R; Gollop G; Greene E
    Rev Panam Salud Publica; 2011 Oct; 30(4):393-400. PubMed ID: 22124699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noncommunicable diseases: global health priority or market opportunity? An illustration of the World Health Organization at its worst and at its best.
    Katz AR
    Int J Health Serv; 2013; 43(3):437-58. PubMed ID: 24066414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure.
    Buse K; Tanaka S; Hawkes S
    Global Health; 2017 Jun; 13(1):34. PubMed ID: 28619031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA.
    Bauer UE; Briss PA; Goodman RA; Bowman BA
    Lancet; 2014 Jul; 384(9937):45-52. PubMed ID: 24996589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global health governance and the challenge of chronic, non-communicable disease.
    Magnusson RS
    J Law Med Ethics; 2010; 38(3):490-507. PubMed ID: 20880237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Global prevention and control of NCDs: Limitations of the standard approach.
    Pearce N; Ebrahim S; McKee M; Lamptey P; Barreto ML; Matheson D; Walls H; Foliaki S; Miranda JJ; Chimeddamba O; Garcia-Marcos L; Haines A; Vineis P
    J Public Health Policy; 2015 Nov; 36(4):408-25. PubMed ID: 26377446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-communicable diseases in Mozambique: risk factors, burden, response and outcomes to date.
    Silva-Matos C; Beran D
    Global Health; 2012 Nov; 8():37. PubMed ID: 23171496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Health promotion and primary prevention strategies to fight chronic disease: a systematic review].
    da Silva LS; Cotta RM; Rosa Cde O
    Rev Panam Salud Publica; 2013 Nov; 34(5):343-50. PubMed ID: 24553762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investing in non-communicable diseases: an estimation of the return on investment for prevention and treatment services.
    Bertram MY; Sweeny K; Lauer JA; Chisholm D; Sheehan P; Rasmussen B; Upreti SR; Dixit LP; George K; Deane S
    Lancet; 2018 May; 391(10134):2071-2078. PubMed ID: 29627159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A priority health index identifies the top six priority risk and related factors for non-communicable diseases in Brazilian cities.
    Simoes EJ; Bouras A; Cortez-Escalante JJ; Malta DC; Porto DL; Mokdad AH; de Moura L; Morais Neto OL
    BMC Public Health; 2015 May; 15():443. PubMed ID: 25924606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From Port-of-Spain summit to United Nations High Level Meeting CARICOM and the global non-communicable disease agenda.
    Samuels TA; Hospedales CJ
    West Indian Med J; 2011 Jul; 60(4):387-91. PubMed ID: 22097668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global Advocacy for Physical Activity (GAPA): global leadership towards a raised profile.
    Blanchard C; Shilton T; Bull F
    Glob Health Promot; 2013 Dec; 20(4 Suppl):113-21. PubMed ID: 24722750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rethinking global health challenges: towards a 'global compact' for reducing the burden of chronic disease.
    Magnusson RS
    Public Health; 2009 Mar; 123(3):265-74. PubMed ID: 19278695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can China achieve a one-third reduction in premature mortality from non-communicable diseases by 2030?
    Li Y; Zeng X; Liu J; Liu Y; Liu S; Yin P; Qi J; Zhao Z; Yu S; Hu Y; He G; Lopez AD; Gao GF; Wang L; Zhou M
    BMC Med; 2017 Jul; 15(1):132. PubMed ID: 28693510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Embedding non-communicable diseases in the post-2015 development agenda.
    Alleyne G; Binagwaho A; Haines A; Jahan S; Nugent R; Rojhani A; Stuckler D;
    Lancet; 2013 Feb; 381(9866):566-74. PubMed ID: 23410606
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.